Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation.

Li, Tian; Ling, Junjun; Du, Xingrong; Zhang, Siyu; Yang, Yan; Zhang, Liang.

Li T; Metabilic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, 646000, China.
Ling J; Drug Discovery Research Center, Southwest Medical University, Luzhou, 646000, China.
Du X; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610000, China.
Zhang S; Affiliated Hospital of Guizhou Medical University, Guiyang, 550000, China.
Yang Y; Metabilic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, 646000, China.
Zhang L; Drug Discovery Research Center, Southwest Medical University, Luzhou, 646000, China.

Nutr Metab (Lond) ; 20(1): 51, 2023 Nov 23.

Article en En | MEDLINE | ID: mdl-37996895